ArticleThe oncologist2022

In Reply: Neoadjuvant TKI Study in Early- and Intermediate Stage Hepatocellular Carcinoma.

Susanne Osanto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.